Alcon AG

ALC · SWISS

$70.17−$0.46 (−0.65%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $70.63

Latest news

Press releaseOct 20, 4:35 PM ETBusiness Wire
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
Press releaseOct 16, 3:57 PM ETBusiness Wire
FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
Press releaseSep 28, 10:15 AM ETBusiness Wire
Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief
Press releaseSep 3, 9:00 AM ETBusiness Wire
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
NewsSep 1, 4:57 AM ETNamrata Sen
Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President
Press releaseAug 26, 5:00 PM ETBusiness Wire
Alcon Prices EUR 500 Million Senior Notes Offering
NewsAug 17, 11:43 AM ETKaustubh Bagalkote
Why Is Netflix Stock Falling on Monday?
NewsAug 13, 2:31 PM ETChandrima Sanyal
Bill Ackman’s New Stock Picks Are Here. These ETFs Could Be Worth Watching
NewsAug 13, 9:19 AM ETRishabh Mishra
Bill Ackman Lost $400 Million on NFLX Stock in 2022 — Now He’s Back With a 3.15M-Share Bet, Saying Netflix Has ‘Won the Streaming Wars’ (UPDATED)
NewsAug 12, 8:06 AM ETAvi Kapoor
National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
NewsAug 10, 5:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsAug 10, 4:31 PM ET
Alcon Q2 Adj. EPS $0.84 Beats $0.75 Estimate, Sales $2.782B Beat $2.769B Estimate
Press releaseAug 10, 4:30 PM ETBusiness Wire
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
NewsAug 10, 3:37 AM ETAvi Kapoor
S&P 500 Surges To Record Close Following Jobs Data: Investor Sentiment Improves, Fear Index Remains in ‘Greed’ Zone
NewsAug 10, 3:08 AM ETAvi Kapoor
Aecom, Alcon And 3 Stocks To Watch Heading Into Monday
Press releaseJul 6, 4:15 PM ETBusiness Wire
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
Press releaseJul 6, 4:15 PM ETGlobe Newswire
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
NewsMay 10, 9:20 AM ETNabaparna Bhattacharya
Zoetis, Insmed, And HubSpot Are Among Top 10 Large-Cap Losers Last Week (May 4-May 8): Are The Others In Your Portfolio?
Press releaseMay 5, 4:30 PM ETBusiness Wire
New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
Press releaseApr 30, 4:30 PM ETBusiness Wire
Alcon Announces Results of 2026 Annual General Meeting
Press releaseApr 7, 12:15 PM ETBusiness Wire
Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada
Press releaseApr 6, 8:03 AM ETBusiness Wire
Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026
Press releaseApr 2, 4:30 PM ETBusiness Wire
Alcon Publishes Agenda for 2026 Annual General Meeting
NewsMar 17, 9:04 AM ETVandana Singh
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review
Press releaseMar 16, 4:57 PM ETBusiness Wire
Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
NewsMar 16, 4:40 PM ET
LENSAR Agrees To Terminate Merger Agreement With Alcon Research
Press releaseMar 2, 8:03 AM ETBusiness Wire
Alcon Surpasses 175 Million IOLs Implanted Globally
Press releaseFeb 24, 4:30 PM ETBusiness Wire
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
NewsFeb 23, 10:01 AM ET
Earnings Preview: Alcon
NewsFeb 18, 5:18 AM ETVandana Singh
FDA Expands Approval For Staar Surgical's Popular Implantable Lens
Press releaseFeb 17, 8:03 AM ETBusiness Wire
Alcon Launches TOTAL30 Multifocal for Astigmatism, the World's Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology
Press releaseFeb 2, 9:02 AM ETBusiness Wire
Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week Fresh
Press releaseJan 20, 4:30 PM ETBusiness Wire
Alcon Completes $750 Million Share Repurchase Program
Press releaseJan 6, 8:00 PM ETBusiness Wire
Alcon Terminates Agreement to Acquire STAAR Surgical
Press releaseJan 6, 9:52 AM ETBusiness Wire
Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon
Press releaseDec 30, 4:30 PM ETBusiness Wire
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
Press releaseDec 19, 12:59 PM ETBusiness Wire
Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon
Press releaseNov 11, 4:30 PM ETBusiness Wire
Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds
Press releaseAug 19, 4:30 PM ETBusiness Wire
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical
Press releaseMay 13, 4:30 PM ETBusiness Wire
Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS
Press releaseApr 4, 1:00 AM ETBusiness Wire
Alcon Publishes Agenda for 2025 Annual General Meeting
Press releaseMar 26, 4:30 PM ETBusiness Wire
Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2

FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes

Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief

Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control

Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President

Alcon Prices EUR 500 Million Senior Notes Offering

Why Is Netflix Stock Falling on Monday?

Bill Ackman’s New Stock Picks Are Here. These ETFs Could Be Worth Watching

Bill Ackman Lost $400 Million on NFLX Stock in 2022 — Now He’s Back With a 3.15M-Share Bet, Saying Netflix Has ‘Won the Streaming Wars’ (UPDATED)

National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session

Alcon Q2 Adj. EPS $0.84 Beats $0.75 Estimate, Sales $2.782B Beat $2.769B Estimate

New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth

S&P 500 Surges To Record Close Following Jobs Data: Investor Sentiment Improves, Fear Index Remains in ‘Greed’ Zone

Aecom, Alcon And 3 Stocks To Watch Heading Into Monday

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Zoetis, Insmed, And HubSpot Are Among Top 10 Large-Cap Losers Last Week (May 4-May 8): Are The Others In Your Portfolio?

New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds

Alcon Announces Results of 2026 Annual General Meeting

Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada

Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026

Alcon Publishes Agenda for 2026 Annual General Meeting

LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

LENSAR Agrees To Terminate Merger Agreement With Alcon Research

Alcon Surpasses 175 Million IOLs Implanted Globally

Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales

Earnings Preview: Alcon

FDA Expands Approval For Staar Surgical's Popular Implantable Lens

Alcon Launches TOTAL30 Multifocal for Astigmatism, the World's Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology

Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week Fresh

Alcon Completes $750 Million Share Repurchase Program

Alcon Terminates Agreement to Acquire STAAR Surgical

Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon

Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference

Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon

Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds

Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical

Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS

Alcon Publishes Agenda for 2025 Annual General Meeting

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease